{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:35:22Z","timestamp":1760146522949,"version":"build-2065373602"},"reference-count":77,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Korean National Research Foundation","award":["NRF-2018R1A2B6007786"],"award-info":[{"award-number":["NRF-2018R1A2B6007786"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Micromachines"],"abstract":"<jats:p>Drug delivery, tissue engineering, and cell promotion in biomedical fields heavily rely on the use of nanomaterials (NMs). When they penetrate cells, NPs undergo degradation and initiate the generation of reactive oxygen species (ROS) by causing changes in the structures of organelles linked to mitochondria. Inside the cell, the excess production of ROS can initiate a chain reaction, along with the autophagy process that helps maintain ROS balance by discarding unnecessary materials. At present, there is no effective treatment for Alzheimer\u2019s disease (AD), a progressive neurodegenerative disease. The use of NMs for siRNA delivery could become a promising treatment for AD and other CNS disorders. Recent research demonstrates that the use of combined NPs can induce autophagy in cells. This article emphasizes the importance of the shape of siRNA-encapsulated NMs in determining their efficiency in delivering and suppressing gene activity in the central nervous system. Because of its strict selectivity against foreign substances, the blood\u2013brain barrier (BBB) significantly hinders the delivery of therapeutic agents to the brain. Conventional chemotherapeutic drugs are significantly less effective against brain cancers due to this limitation. As a result, NMs have become a promising approach for targeted drug delivery, as they can be modified to carry specific ligands that direct them to their intended targets. This review thoroughly examines the latest breakthroughs in using NMs to deliver bioactive compounds across the BBB, focusing on their use in cancer treatments. The review starts by examining the structure and functions of the BBB and BBTB, and then emphasizes the benefits that NMs offer.<\/jats:p>","DOI":"10.3390\/mi15111382","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T08:28:13Z","timestamp":1731659293000},"page":"1382","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the Connection Between Nanomaterials and Neurodegenerative Disorders"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7663-4830","authenticated-orcid":false,"given":"Sitansu Sekhar","family":"Nanda","sequence":"first","affiliation":[{"name":"Department of Chemistry, Myongji University, Yongin 17058, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2604-9323","authenticated-orcid":false,"given":"Dong Kee","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Myongji University, Yongin 17058, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"14805","DOI":"10.1021\/acsomega.9b01392","article-title":"Inhibition of glycation-induced aggregation of human serum albumin by organic\u2013inorganic hybrid nanocomposites of iron oxide-functionalized nanocellulose","volume":"4","author":"Singla","year":"2019","journal-title":"ACS Omega"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/09205063.2015.1133155","article-title":"Dendrimer-mediated approaches for the treatment of brain tumor","volume":"27","author":"Dwivedi","year":"2016","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1474-4422(07)70326-5","article-title":"Strategies to advance translational research into brain barriers","volume":"7","author":"Neuwelt","year":"2008","journal-title":"Lancet Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12987-020-00191-7","article-title":"Recent advances in human iPSC- derived models of the blood\u2212brain barrier","volume":"17","author":"Workman","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/neuonc\/noaa101","article-title":"A combined approach of convection- enhanced delivery of peptide nanofiber reservoir to prolong local DM1 retention for diffuse intrinsic pontine glioma treatment","volume":"22","author":"Bellat","year":"2020","journal-title":"Neuro-Oncology"},{"doi-asserted-by":"crossref","unstructured":"Di Marco, A., Vignone, D., Paz, O.G., Fini, I., Battista, M.R., Cellucci, A., Bracacel, E., Auciello, G., Veneziano, M., and Khetarpal, V. (2020). Establishment of an in vitro human blood-brain barrier model derived from induced pluripotent stem cells and comparison to a porcine cell-based system. Cells, 9.","key":"ref_7","DOI":"10.3390\/cells9040994"},{"key":"ref_8","first-page":"265","article-title":"Nanotechnology and drug delivery part 1: Background and applications","volume":"8","author":"Ochekpe","year":"2009","journal-title":"Trop. J. Pharm. Res."},{"doi-asserted-by":"crossref","unstructured":"Xie, J.B., Shen, Z.Y., Anraku, Y., Kataoka, K., and Chen, X.Y. (2019). Nanomaterial-based blood-brain-barrier (BBB) crossing strategies. Biomaterials, 224.","key":"ref_9","DOI":"10.1016\/j.biomaterials.2019.119491"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1800080","DOI":"10.1002\/adhm.201800080","article-title":"An intelligent neural stem cell delivery system for neurodegenerative diseases treatment","volume":"7","author":"Qiao","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1016\/j.biomaterials.2012.06.063","article-title":"Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor","volume":"33","author":"Prades","year":"2012","journal-title":"Biomaterials"},{"unstructured":"GBD 2016 Lower Respiratory Infections Collaborators (2018). Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect. Dis., 18, 1211\u20131228.","key":"ref_12"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1021\/acschemneuro.0c00216","article-title":"A master regulator of \u03b1-synuclein aggregation","volume":"11","author":"Tripathi","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1021\/acsomega.7b00459","article-title":"Study of molecular mechanisms of \u03b1-synuclein assembly: Insight into a cross-\u03b2 structure in the N-termini of new \u03b1-synuclein fibrils","volume":"2","author":"Bloch","year":"2017","journal-title":"ACS Omega"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neulet.2017.12.001","article-title":"Suppression of autophagy in the brain of transgenic mice with overexpression of A53T-mutant \u03b1-synuclein as an early event at synucleinopathy progression","volume":"672","author":"Pupyshev","year":"2018","journal-title":"Neurosci. Lett."},{"key":"ref_16","first-page":"3801","article-title":"Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity","volume":"24","author":"Wanli","year":"2005","journal-title":"Hum. Mol. Genet."},{"doi-asserted-by":"crossref","unstructured":"Zondler, L., Kostka, M., Garidel, P., Heinzelmann, U., Hengerer, B., Mayer, B., Weishaupt, J.H., Gillardon, F., and Danzer, K.M. (2017). Proteasome impairment by \u03b1-synuclein. PLoS ONE, 12.","key":"ref_17","DOI":"10.1371\/journal.pone.0184040"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40478-017-0470-4","article-title":"Transmission of \u03b1-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: Another mechanism for initiation and progression of Parkinson\u2019s disease?","volume":"5","author":"Matsumoto","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"doi-asserted-by":"crossref","unstructured":"Maddahi, A., Polyvyana, A., Nassiri, A.M., Maddahi, Y., and Choukou, M.A. (2020, January 27\u201329). Caring4Dementia: A Mobile Application to Train People Caring for Patients with Dementia. Proceedings of the 11th Augmented Human International Conference, Winnipeg, MB, Canada.","key":"ref_19","DOI":"10.1145\/3396339.3396342"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","article-title":"The physiological roles of tau and A\u03b2: Implications for Alzheimer\u2019s disease pathology and therapeutics","volume":"140","author":"Kent","year":"2020","journal-title":"Acta Neuropathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1073\/pnas.83.11.4044","article-title":"Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease","volume":"83","author":"KoSIK","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","article-title":"Interactions of pathological proteins in neurodegenerative diseases","volume":"134","author":"Attems","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.2949367","article-title":"Amyloid \u03b2 protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus","volume":"235","author":"Tanzi","year":"1987","journal-title":"Science"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"\u03b2-Secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"ref_26","first-page":"457","article-title":"Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: Correlation with cognitive severity","volume":"27","author":"DeKosky","year":"1990","journal-title":"Ann. Neurol. Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1083\/jcb.201806205","article-title":"A cellular complex of BACE1 and \u03b3-secretase sequentially generates A\u03b2 from its full-length precursor","volume":"218","author":"Liu","year":"2019","journal-title":"J. Cell Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","article-title":"Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease","volume":"15","author":"Guo","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"12384","DOI":"10.1073\/pnas.1706248114","article-title":"Oxalate-curcumin\u2013based probe for micro-and macroimaging of reactive oxygen species in Alzheimer\u2019s disease","volume":"114","author":"Yang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1474-9726.2012.00848.x","article-title":"Endoplasmic reticulum stress occurs downstream of GluN2B subunit of N-methyl-D-aspartate receptor in mature hippocampal cultures treated with amyloid-\u03b2 oligomers","volume":"11","author":"Costa","year":"2012","journal-title":"Aging Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1039\/C6CS00731G","article-title":"Towards an understanding of amyloid-\u03b2 oligomers: Characterization, toxicity mechanisms, and inhibitors","volume":"46","author":"Lee","year":"2017","journal-title":"Chem. Soc. Rev."},{"doi-asserted-by":"crossref","unstructured":"Meng, X., Song, Q., Liu, Z., Liu, X., Wang, Y., and Liu, J. (2024). Neurotoxic \u03b2-amyloid oligomers cause mitochondrial dysfunction\u2014The trigger for PANoptosis in neurons. Front. Aging Neurosci., 16.","key":"ref_32","DOI":"10.3389\/fnagi.2024.1400544"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jtemb.2014.05.003","article-title":"Copper mediated neurological disorder: Visions into amyotrophic lateral sclerosis, Alzheimer and Menkes disease","volume":"29","author":"Ahuja","year":"2015","journal-title":"J. Trace Elem. Med. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13024-021-00464-1","article-title":"Accumulation of saposin in dystrophic neurites is linked to impaired lysosomal functions in Alzheimer\u2019s disease brains","volume":"16","author":"Sharoar","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40035-020-00189-z","article-title":"Current understanding of metal ions in the pathogenesis of Alzheimer\u2019s disease","volume":"9","author":"Wang","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"eaay6931","DOI":"10.1126\/scitranslmed.aay6931","article-title":"\u03b2-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3\u03b2\/tau cascade","volume":"12","author":"Zhang","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/alz.12192","article-title":"Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer\u2019s disease","volume":"17","author":"Arnsten","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1038\/s41467-021-26851-2","article-title":"Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"doi-asserted-by":"crossref","unstructured":"Elliott, J.H., Wightman, F., Solomon, A., Ghneim, K., Ahlers, J., Cameron, M.J., Smith, M.Z., Tim Spelman, T., McMahon, J., and Velayudham, P. (2014). Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy. PLoS Pathog., 10.","key":"ref_40","DOI":"10.1371\/journal.ppat.1004473"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.neuron.2015.10.012","article-title":"Hsc70-4 deforms membranes to promote synaptic protein turnover by endosomal microautophagy","volume":"88","author":"Uytterhoeven","year":"2015","journal-title":"Neuron"},{"key":"ref_42","first-page":"1313","article-title":"Moxibustion at acpoints of governor vessel on regulating PI3K\/Akt\/mTOR signaling pathway and enhancing autophagy process in APP\/PS1 double-transgenic Alzheimer\u2019s disease mice","volume":"39","author":"Zhang","year":"2019","journal-title":"Zhongguo Zhen Jiu Chin. Acupunct. Moxibustion"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ncl.2014.09.003","article-title":"Huntington Disease: Pathogenesis and Treatment","volume":"33","author":"Dayalu","year":"2015","journal-title":"Neurol. Clin."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","article-title":"The hunt for huntingtin function: Interaction partners tell many different stories","volume":"28","author":"Harjes","year":"2003","journal-title":"Trends Biochem. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: An alternative approach to Huntington\u2019s disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ncb3101","article-title":"Huntingtin functions as a scaffold for selective macroautophagy","volume":"17","author":"Rui","year":"2015","journal-title":"Nat. Cell Biol."},{"doi-asserted-by":"crossref","unstructured":"Zheng, S., Clabough, E.B., Sarkar, S., Futter, M., Rubinsztein, D.C., and Zeitlin, S.O. (2010). Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice. PLoS Genet., 6.","key":"ref_47","DOI":"10.1371\/journal.pgen.1000838"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.4103\/2152-7806.91612","article-title":"Pitfalls in precision stereotactic surgery","volume":"3","author":"Zrinzo","year":"2012","journal-title":"Surg. Neurol. Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41582-018-0128-2","article-title":"Deep brain stimulation: Current challenges and future directions","volume":"15","author":"Lozano","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/acschemneuro.9b00541","article-title":"Tuning properties for blood\u2013brain barrier permeation: A statistics-based analysis","volume":"11","author":"Dichiara","year":"2019","journal-title":"ACS Chem. Neurosci."},{"doi-asserted-by":"crossref","unstructured":"Banks, W.A. (2009). Characteristics of compounds that cross the blood-brain barrier. BMC Neurol., 9.","key":"ref_51","DOI":"10.1186\/1471-2377-9-S1-S3"},{"doi-asserted-by":"crossref","unstructured":"Pulgar, V.M. (2019). Transcytosis to cross the blood brain barrier, new advancements and challenges. Front. Neurosci., 12.","key":"ref_52","DOI":"10.3389\/fnins.2018.01019"},{"doi-asserted-by":"crossref","unstructured":"Kou, L., Bhutia, Y.D., Yao, Q., He, Z., Sun, J., and Ganapathy, V. (2018). Transporter-guided delivery of nanoparticles to improve drug permeation across cellular barriers and drug exposure to selective cell types. Front. Pharmacol., 9.","key":"ref_53","DOI":"10.3389\/fphar.2018.00027"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrn1007","article-title":"Unfolding the role of protein misfolding in neurodegenerative diseases","volume":"4","author":"Soto","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nn1531","article-title":"Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model","volume":"8","author":"Singer","year":"2005","journal-title":"Nat. Neurosci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1038\/mtna.2015.15","article-title":"Intraventricular delivery of siRNA nanoparticles to the central nervous system","volume":"4","author":"Shyam","year":"2015","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2018.04.034","article-title":"Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer\u2019s disease","volume":"279","author":"Wang","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1601666","DOI":"10.1002\/smll.201601666","article-title":"Design of a molecular hybrid of dual peptide inhibitors coupled on AuNPs for enhanced inhibition of amyloid \u03b2-protein aggregation and cytotoxicity","volume":"13","author":"Xiong","year":"2017","journal-title":"Small"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/B978-0-12-416020-0.00005-X","article-title":"Carbon nanotubes: Engineering biomedical applications","volume":"104","author":"Burgos","year":"2011","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/1389200219666171221122119","article-title":"Promoting inter-\/intra-cellular process of nanomedicine through its physicochemical properties optimization","volume":"19","author":"Chen","year":"2018","journal-title":"Curr. Drug Metab."},{"doi-asserted-by":"crossref","unstructured":"Sabourian, P., Yazdani, G., Ashraf, S.S., Frounchi, M., Mashayekhan, S., Kiani, S., and Kakkar, A. (2020). Effect of physico-chemical properties of nanoparticles on their intracellular uptake. Int. J. Mol. Sci., 21.","key":"ref_61","DOI":"10.3390\/ijms21218019"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0196-6553(89)90172-7","article-title":"Evaluation of the insulin jet injector as a potential source of infection","volume":"17","author":"Price","year":"1989","journal-title":"Am. J. Infect. Control"},{"doi-asserted-by":"crossref","unstructured":"Teleanu, D.M., Chircov, C., Grumezescu, A.M., Volceanov, A., and Teleanu, R.I. (2018). Blood-brain delivery methods using nanotechnology. Pharmaceutics, 10.","key":"ref_63","DOI":"10.3390\/pharmaceutics10040269"},{"doi-asserted-by":"crossref","unstructured":"Gaba, B., Khan, T., Haider, M.F., Alam, T., Baboota, S., Parvez, S., and Ali, J. (2019). Vitamin E Loaded Naringenin Nanoemulsion via Intranasal Delivery for the Management of Oxidative Stress in a 6-OHDA Parkinson\u2019s Disease Model. BioMed Res. Int., 2019.","key":"ref_64","DOI":"10.1155\/2019\/2382563"},{"doi-asserted-by":"crossref","unstructured":"Marcuzzo, S., Isaia, D., Bonanno, S., Malacarne, C., Cavalcante, P., Zacheo, A., Laquintana, V., Denora, N., Sanavio, B., and Salvati, E. (2019). FM19G11-loaded gold nanoparticles enhance the proliferation and self-renewal of ependymal stem progenitor cells derived from ALS mice. Cells, 8.","key":"ref_65","DOI":"10.3390\/cells8030279"},{"doi-asserted-by":"crossref","unstructured":"Inglut, C.T., Sorrin, A.J., Kuruppu, T., Vig, S., Cicalo, J., Ahmad, H., and Huang, H.C. (2020). Immunological and toxicological considerations for the design of liposomes. Nanomaterials, 10.","key":"ref_66","DOI":"10.3390\/nano10020190"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","article-title":"Peripheral anti-A\u03b2 antibody alters CNS and plasma A\u03b2 clearance and decreases brain A\u03b2 burden in a mouse model of Alzheimer\u2019s disease","volume":"98","author":"DeMattos","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.omtn.2017.08.013","article-title":"Polyethylenimine nanoparticle-mediated siRNA delivery to reduce \u03b1-Synuclein expression in a model of Parkinson\u2019s disease","volume":"9","author":"Helmschrodt","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2404234","DOI":"10.1002\/adfm.202404234","article-title":"Lipid Nanoparticles: Versatile Drug Delivery Vehicles for Traversing the Blood Brain Barrier to Treat Brain Cancer","volume":"34","author":"Cai","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1002\/mco2.327","article-title":"Nanoparticles-induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation models","volume":"4","author":"Xuan","year":"2023","journal-title":"MedComm"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2301527","DOI":"10.1002\/adhm.202301527","article-title":"Noninvasive Treatment of Alzheimer\u2019s Disease with Scintillating Nanotubes","volume":"12","author":"Senapati","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/1097-0142(20011001)92:7<1936::AID-CNCR1712>3.0.CO;2-H","article-title":"Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin","volume":"92","author":"Fabel","year":"2001","journal-title":"Cancer"},{"key":"ref_73","first-page":"1199","article-title":"Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma","volume":"100","author":"Hau","year":"2004","journal-title":"Cancer Interdiscip. Int. J. Am. Cancer Soc."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"iv157","DOI":"10.1093\/annonc\/mdu331.32","article-title":"Phase 1\/2a study of glutathione pegylated liposomal doxorubicin (2b3-101) in patients with brain metastases (BM) from solid tumors or recurrent high grade gliomas (HGG)","volume":"25","author":"Brandsma","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00280-017-3247-3","article-title":"A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma","volume":"79","author":"Clarke","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"100365","DOI":"10.1016\/j.esmoop.2021.100365","article-title":"Targeting immunoliposomes to EGFR-positive glioblastoma","volume":"7","author":"Kasenda","year":"2022","journal-title":"ESMO Open"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2311670","DOI":"10.1002\/smll.202311670","article-title":"Multifunctional Liposomes Targeting Amyloid-\u03b2 Oligomers for Early Diagnosis and Therapy of Alzheimer\u2019s Disease","volume":"20","author":"Senapati","year":"2024","journal-title":"Small"}],"container-title":["Micromachines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-666X\/15\/11\/1382\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:33:08Z","timestamp":1760113988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-666X\/15\/11\/1382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":77,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["mi15111382"],"URL":"https:\/\/doi.org\/10.3390\/mi15111382","relation":{},"ISSN":["2072-666X"],"issn-type":[{"type":"electronic","value":"2072-666X"}],"subject":[],"published":{"date-parts":[[2024,11,15]]}}}